<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36832013</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2079-6374</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Biosensors</Title><ISOAbbreviation>Biosensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>Electrochemical Impedance Immunoassay for ALS-Associated Neurofilament Protein: Matrix Effect on the Immunoplatform.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">247</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/bios13020247</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder, which has complex diagnostic steps. Electrochemical immunoassays may make the diagnosis simpler and faster. Here, we present the detection of ALS-associated neurofilament light chain (Nf-L) protein through an electrochemical impedance immunoassay on reduced graphene oxide (rGO) screen-printed electrodes. The immunoassay was developed in two different media, i.e., buffer and human serum, to compare the effect of the media on their figures of merit and calibration models. The label-free charge transfer resistance (R<sub>CT</sub>) of the immunoplatform was used as a signal response to develop the calibration models. We found that exposure of the biorecognition layer to human serum improved the impedance response of the biorecognition element with significantly lower relative error. Moreover, the calibration model obtained in the human serum environment has higher sensitivity and a better limit of detection (0.087 ng/mL) than the buffer medium (0.39 ng/mL). The analyses of the ALS patient samples show that concentrations obtained from the buffer-based regression model was higher than the serum-based model. However, a high Pearson correlation (r = 1.00) between the media suggests that concentration in one medium may be useful to predict the concentration in the other medium. Moreover, the Nf-L concentration appears to increase with age in both male and female groups, while overall higher Nf-L was found in the male group than the female group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adil</LastName><ForeName>Omair</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>School of Chemical and Biomolecular Sciences, Southern Illinois University, 1245 Lincoln Drive, Carbondale, IL 62918, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shamsi</LastName><ForeName>Mohtashim H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-5463-811X</Identifier><AffiliationInfo><Affiliation>School of Chemical and Biomolecular Sciences, Southern Illinois University, 1245 Lincoln Drive, Carbondale, IL 62918, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N/A</GrantID><Agency>Neurodegenerative Research Inc.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biosensors (Basel)</MedlineTA><NlmUniqueID>101609191</NlmUniqueID><ISSNLinking>2079-6374</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016900">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016900" MajorTopicYN="Y">Neurofilament Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017097" MajorTopicYN="N">Electric Impedance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004566" MajorTopicYN="N">Electrodes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">diagnostics</Keyword><Keyword MajorTopicYN="N">electrochemical impedance spectroscopy</Keyword><Keyword MajorTopicYN="N">immunoassay</Keyword><Keyword MajorTopicYN="N">neurofilament-light</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36832013</ArticleId><ArticleId IdType="pmc">PMC9954657</ArticleId><ArticleId IdType="doi">10.3390/bios13020247</ArticleId><ArticleId IdType="pii">bios13020247</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Amyotrophic Lateral Sclerosis (ALS) Fact Sheet.  [(accessed on 28 September 2022)]; Available online:  https://www.ninds.nih.gov/amyotrophic-lateral-sclerosis-als-fact-sheet#:~:text=There%20is%20no%20single%20test,to%20rule%20out%20other%20diseases.</Citation></Reference><Reference><Citation>Wijesekera L.C., Nigel Leigh P. Amyotrophic lateral sclerosis. Orphanet. J. Rare Dis. 2009;4:1&#x2013;22. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats K.A., Borchelt D.R., Tansey M.G., Wymer J. Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Mol. Neurodegener. 2022;17:11. doi: 10.1186/s13024-022-00515-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00515-1</ArticleId><ArticleId IdType="pmc">PMC8785449</ArticleId><ArticleId IdType="pubmed">35073950</ArticleId></ArticleIdList></Reference><Reference><Citation>Robelin L., Gonzalez De Aguilar J.L. Blood biomarkers for amyotrophic lateral sclerosis: Myth or reality? Biomed. Res. Int. 2014;2014:525097. doi: 10.1155/2014/525097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/525097</ArticleId><ArticleId IdType="pmc">PMC4060749</ArticleId><ArticleId IdType="pubmed">24991560</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Silani V., Otto M. Neurochemical biomarkers in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2019;32:747&#x2013;757. doi: 10.1097/WCO.0000000000000744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000744</ArticleId><ArticleId IdType="pubmed">31403480</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga A., Maragakis N.J. Current and emerging ALS biomarkers: Utility and potential in clinical trials. Expert Rev. Neurother. 2018;18:871&#x2013;886. doi: 10.1080/14737175.2018.1530987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2018.1530987</ArticleId><ArticleId IdType="pubmed">30273061</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyappayil A., Yagati A.K., Lee M.H. Recent Trends in Metal Nanoparticles Decorated 2D Materials for Electrochemical Biomarker Detection. Biosensors. 2023;13:91. doi: 10.3390/bios13010091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bios13010091</ArticleId><ArticleId IdType="pmc">PMC9855691</ArticleId><ArticleId IdType="pubmed">36671926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.Y., Nhat Nguyen U.T., Hsieh H.Y., Tahara H., Chang Y.S., Wang B.Y., Gu B.C., Dai Y.H., Wu C.C., Tsai I.J., et al. Peptide-based electrochemical sensor with nanogold enhancement for detecting rheumatoid arthritis. Talanta. 2022;236:122886. doi: 10.1016/j.talanta.2021.122886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.talanta.2021.122886</ArticleId><ArticleId IdType="pubmed">34635266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.S., Huang C.H., Pai P.C., Seo J., Lei K.F. A Review on Microfluidics-Based Impedance Biosensors. Biosensors. 2023;13:83. doi: 10.3390/bios13010083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bios13010083</ArticleId><ArticleId IdType="pmc">PMC9855525</ArticleId><ArticleId IdType="pubmed">36671918</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Shamsi M.H. Biosensors-on-Chip: A Topical Review. J. Micromech. Microeng. 2017;27:083001&#x2013;083015. doi: 10.1088/1361-6439/aa7117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1361-6439/aa7117</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Qamar A.Z., Asefifeyzabadi N., Funneman M., Taki M., Elliot L., Kinsel M.E., Kinsel G.R., Shamsi M.H. Hand-fabricated CNT/AgNPs electrodes using wax-on-plastic platforms for electro-immunosensing application. Sci. Rep. 2019;9:6131. doi: 10.1038/s41598-019-42644-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42644-6</ArticleId><ArticleId IdType="pmc">PMC6467877</ArticleId><ArticleId IdType="pubmed">30992528</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheen H.J., Panigrahi B., Kuo T.R., Hsu W.C., Chung P.S., Xie Q.Z., Lin C.Y., Chang Y.S., Lin C.T., Fan Y.J. Electrochemical biosensor with electrokinetics-assisted molecular trapping for enhancing C-reactive protein detection. Biosens. Bioelectron. 2022;210:114338. doi: 10.1016/j.bios.2022.114338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2022.114338</ArticleId><ArticleId IdType="pubmed">35550939</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta P., Lu Y.J., Hsieh H.Y., Lee T.Y., Lee Y.T., Cheng C.M., Fan Y.J. Detection of Candida albicans Using a Manufactured Electrochemical Sensor. Micromachines. 2021;12:166. doi: 10.3390/mi12020166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/mi12020166</ArticleId><ArticleId IdType="pmc">PMC7915424</ArticleId><ArticleId IdType="pubmed">33567542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Yang Y., Min J., Song Y., Tu J., Mukasa D., Ye C., Xu C., Heflin N., McCune J.S., et al. A wearable electrochemical biosensor for the monitoring of metabolites and nutrients. Nat. Biomed. Eng. 2022;6:1225&#x2013;1235. doi: 10.1038/s41551-022-00916-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-022-00916-z</ArticleId><ArticleId IdType="pubmed">35970928</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson H., Bacon A., Joseph K.M., Gwandaru W.R.W., Bhide A., Sankhala D., Dhamu V.N., Prasad S. A Rapid Response Electrochemical Biosensor for Detecting Thc In Saliva. Sci. Rep. 2019;9:12701. doi: 10.1038/s41598-019-49185-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49185-y</ArticleId><ArticleId IdType="pmc">PMC6722119</ArticleId><ArticleId IdType="pubmed">31481686</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho I.H., Kim D.H., Park S. Electrochemical biosensors: Perspective on functional nanomaterials for on-site analysis. Biomater. Res. 2020;24:6. doi: 10.1186/s40824-019-0181-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40824-019-0181-y</ArticleId><ArticleId IdType="pmc">PMC7001310</ArticleId><ArticleId IdType="pubmed">32042441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C., Yang G., Li H., Du D., Lin Y. Electrochemical sensors and biosensors based on nanomaterials and nanostructures. Anal. Chem. 2015;87:230&#x2013;249. doi: 10.1021/ac5039863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac5039863</ArticleId><ArticleId IdType="pmc">PMC4287168</ArticleId><ArticleId IdType="pubmed">25354297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi J., Van Bulck M., Suhail A., Safarzadeh M., Perez-Castillo A., Pan G. A label-free biosensor based on graphene and reduced graphene oxide dual-layer for electrochemical determination of beta-amyloid biomarkers. Microchim. Acta. 2020;187:288. doi: 10.1007/s00604-020-04267-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00604-020-04267-x</ArticleId><ArticleId IdType="pmc">PMC7182627</ArticleId><ArticleId IdType="pubmed">32333119</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena-Bahamonde J., Nguyen H.N., Fanourakis S.K., Rodrigues D.F. Recent advances in graphene-based biosensor technology with applications in life sciences. J. Nanobiotechnol. 2018;16:75. doi: 10.1186/s12951-018-0400-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-018-0400-z</ArticleId><ArticleId IdType="pmc">PMC6150956</ArticleId><ArticleId IdType="pubmed">30243292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg H., Bowser R. Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev. Proteom. 2008;5:249&#x2013;262. doi: 10.1586/14789450.5.2.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14789450.5.2.249</ArticleId><ArticleId IdType="pubmed">18466055</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G., Biferi M.G., Pradat P.F. Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials. J. Neuromuscul. Dis. 2022;9:25&#x2013;37. doi: 10.3233/JND-210754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-210754</ArticleId><ArticleId IdType="pmc">PMC8842771</ArticleId><ArticleId IdType="pubmed">34864683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreger M., Steinbach R., Otto M., Turner M.R., Grosskreutz J. Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2022;93:422&#x2013;435. doi: 10.1136/jnnp-2021-327503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327503</ArticleId><ArticleId IdType="pmc">PMC8921583</ArticleId><ArticleId IdType="pubmed">35105727</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Qin X., Chang X., Wang H., Guo J., Zhang W. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J. Cell Mol. Med. 2022;26:583&#x2013;587. doi: 10.1111/jcmm.17100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17100</ArticleId><ArticleId IdType="pmc">PMC8743649</ArticleId><ArticleId IdType="pubmed">34866307</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Steinacker P., Weishaupt J.H., Kassubek J., Oeckl P., Halbgebauer S., Tumani H., von Arnim C.A.F., Dorst J., Feneberg E., et al. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2019;90:157&#x2013;164. doi: 10.1136/jnnp-2018-318704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318704</ArticleId><ArticleId IdType="pubmed">30309882</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaiottino J., Norgren N., Dobson R., Topping J., Nissim A., Malaspina A., Bestwick J.P., Monsch A.U., Regeniter A., Lindberg R.L., et al. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS ONE. 2013;8:e75091. doi: 10.1371/journal.pone.0075091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075091</ArticleId><ArticleId IdType="pmc">PMC3779219</ArticleId><ArticleId IdType="pubmed">24073237</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayat A., Barthelmebs L., Marty J.-L. Electrochemical impedimetric immunosensor for the detection of okadaic acid in mussel sample. Sens. Actuators B Chem. 2012;171&#x2013;172:810&#x2013;815. doi: 10.1016/j.snb.2012.05.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.snb.2012.05.075</ArticleId></ArticleIdList></Reference><Reference><Citation>Eissa S., Jimenez G.C., Mahvash F., Guermoune A., Tlili C., Szkopek T., Zourob M., Siaj M. Functionalized CVD monolayer graphene for label-free impedimetric biosensing. Nano Res. 2015;8:1698&#x2013;1709. doi: 10.1007/s12274-014-0671-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12274-014-0671-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Liu D., Chen J., Xiang C., Xiang J., Yang M. Electrochemical Quantitation of the Glycosylation Level of Serum Neurofilament Light Chain for the Diagnosis of Neurodegeneration: An Interface-Solution Dual-Path Amplification Strategy. Anal. Chem. 2022;94:11433&#x2013;11440. doi: 10.1021/acs.analchem.2c02753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.2c02753</ArticleId><ArticleId IdType="pubmed">35913270</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W.-t., Dong S.-y., Chen H., An Y.-q., Zhang J., Wang L.-y., Zhu J.-J. A neurofilament-light chains electrochemical immunosensor expected to reveal the early stage of neurodegenerative diseases. Chem. Eng. J. 2022;446:136850. doi: 10.1016/j.cej.2022.136850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cej.2022.136850</ArticleId></ArticleIdList></Reference><Reference><Citation>Valverde A., Montero-Calle A., Barderas R., Calero M., Y&#xe1;&#xf1;ez-Sede&#xf1;o P., Campuzano S., Pingarr&#xf3;n J.M. Electrochemical immunoplatform to unravel neurodegeneration and Alzheimer&#x2019;s disease through the determination of neurofilament light protein. Electrochim. Acta. 2021;371:137815. doi: 10.1016/j.electacta.2021.137815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.electacta.2021.137815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferapontova E.E., Gothelf K.V. Effect of serum on an RNA aptamer-based electrochemical sensor for theophylline. Langmuir. 2009;25:4279&#x2013;4283. doi: 10.1021/la804309j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/la804309j</ArticleId><ArticleId IdType="pubmed">19301828</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Otto M., Silani V. Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front Neurosci. 2021;15:679199. doi: 10.3389/fnins.2021.679199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.679199</ArticleId><ArticleId IdType="pmc">PMC8255624</ArticleId><ArticleId IdType="pubmed">34234641</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E., Oeckl P., Steinacker P., Verde F., Barro C., Van Damme P., Gray E., Grosskreutz J., Jardel C., Kuhle J., et al. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology. 2018;90:e22&#x2013;e30. doi: 10.1212/WNL.0000000000004761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004761</ArticleId><ArticleId IdType="pubmed">29212830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P.Y., Osman J., Low T.Y., Jamal R. Plasma/serum proteomics: Depletion strategies for reducing high-abundance proteins for biomarker discovery. Bioanalysis. 2019;11:1799&#x2013;1812. doi: 10.4155/bio-2019-0145.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/bio-2019-0145</ArticleId><ArticleId IdType="pubmed">31617391</ArticleId></ArticleIdList></Reference><Reference><Citation>Halbgebauer S., Steinacker P., Verde F., Weishaupt J., Oeckl P., von Arnim C., Dorst J., Feneberg E., Mayer B., Rosenbohm A., et al. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS. J. Neurol. Neurosurg. Psychiatry. 2022;93:68&#x2013;74. doi: 10.1136/jnnp-2021-327129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327129</ArticleId><ArticleId IdType="pubmed">34417339</ArticleId></ArticleIdList></Reference><Reference><Citation>De Schaepdryver M., Lunetta C., Tarlarini C., Mosca L., Chio A., Van Damme P., Poesen K. Neurofilament light chain and C reactive protein explored as predictors of survival in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2020;91:436&#x2013;437. doi: 10.1136/jnnp-2019-322309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322309</ArticleId><ArticleId IdType="pubmed">32029541</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M., Wuu J., Lombardi V., Jeromin A., Bowser R., Andersen P.M., Malaspina A. Neurofilaments in pre-symptomatic ALS and the impact of genotype. Amyotroph. Lateral Scler. Front. Degener. 2019;20:538&#x2013;548. doi: 10.1080/21678421.2019.1646769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1646769</ArticleId><ArticleId IdType="pmc">PMC6768722</ArticleId><ArticleId IdType="pubmed">31432691</ArticleId></ArticleIdList></Reference><Reference><Citation>Swindell W.R., Kruse C.P.S., List E.O., Berryman D.E., Kopchick J.J. ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia. J. Transl. Med. 2019;17:170. doi: 10.1186/s12967-019-1909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1909-0</ArticleId><ArticleId IdType="pmc">PMC6530130</ArticleId><ArticleId IdType="pubmed">31118040</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>